These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 742500)

  • 21. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of different subcellular fractions of Vibrio cholerae O139 in protection to challenge in experimental cholera.
    Bondre VP; Sinha VB; Srivastava BS
    FEMS Immunol Med Microbiol; 1997 Dec; 19(4):323-9. PubMed ID: 9537758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical, histological and ultrastructural evaluation of protection provided by cholera vaccine against V. cholerae O139.
    Murugaiah C; Nik Mohd Noor NZ; Al-Talib H; Mustafa S; Manickam R; Pattabhiraman L
    Microb Pathog; 2020 Mar; 140():103964. PubMed ID: 31904450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
    Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
    FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine.
    Resnick IG; Ford CW; Shackleford GM; Berry LJ
    Infect Immun; 1980 Nov; 30(2):375-80. PubMed ID: 7439983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral vaccination with Lactococcus lactis expressing the Vibrio cholerae Wzm protein to enhance mucosal and systemic immunity.
    Zamri HF; Shamsudin MN; Rahim RA; Neela V
    Vaccine; 2012 May; 30(21):3231-8. PubMed ID: 22426330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.
    Rollenhagen JE; Kalsy A; Cerda F; John M; Harris JB; Larocque RC; Qadri F; Calderwood SB; Taylor RK; Ryan ET
    Infect Immun; 2006 Oct; 74(10):5834-9. PubMed ID: 16988262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress in cholera vaccination.
    Pierre PG; Lucas G; Van Damme M; Vaerman JP
    Acta Gastroenterol Belg; 1992; 55(5-6):430-6. PubMed ID: 1288041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiopathology of diarrhea in cholera].
    Thomas J; Josserand C; André LJ
    Arch Fr Mal App Dig; 1974 Jun; 63(4):327-41. PubMed ID: 4376678
    [No Abstract]   [Full Text] [Related]  

  • 33. Current status of cholera and rise of novel mucosal vaccine.
    Yamamoto T
    Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro degradation of mouse, rabbit and dog antibodies to Vibrio cholerae by succus entericus.
    Horsfall DJ; Heddle RJ; Gormly AA; Rowley D
    Aust J Exp Biol Med Sci; 1978 Dec; 56(6):681-93. PubMed ID: 752309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A one dose experimental cholera vaccine.
    Muse M; Grandjean C; Wade TK; Wade WF
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):98-115. PubMed ID: 22612159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RpoS controls the Vibrio cholerae mucosal escape response.
    Nielsen AT; Dolganov NA; Otto G; Miller MC; Wu CY; Schoolnik GK
    PLoS Pathog; 2006 Oct; 2(10):e109. PubMed ID: 17054394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisera to selected outer membrane proteins of Vibrio cholerae protect against challenge with homologous and heterologous strains of V. cholerae.
    Das M; Chopra AK; Cantu JM; Peterson JW
    FEMS Immunol Med Microbiol; 1998 Dec; 22(4):303-8. PubMed ID: 9879921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretory IgA antibodies to enterobacterial virulence antigens: their induction and possible relevance.
    Hanson LA; Ahlstedt S; Carlsson B; Kaijser B; Larsson P; Baltzer IM; Akerlund AS; Edén CS; Svennerholm AM
    Adv Exp Med Biol; 1978; 107():165-76. PubMed ID: 369311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea.
    Sánchez J; Holmgren J
    Curr Opin Immunol; 2005 Aug; 17(4):388-98. PubMed ID: 15963708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.